UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of genomics on drug discovery and clinical medicine

QJM : An International Journal of Medicine, 2000-07, Vol.93 (7), p.391-423

2000

Volltextzugriff (PDF)

Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia

International journal of geriatric psychiatry, 2000-08, Vol.15 (8), p.704-712

2000

Volltextzugriff (PDF)

Dopamine receptorsâphysiological understanding to therapeutic intervention potential

Pharmacology & therapeutics (Oxford), 1999-11, Vol.84 (2), p.133-156

Emilien, G

1999

Volltextzugriff (PDF)

Current therapeutic uses and potential of β-adrenoceptor agonists and antagonists

European journal of clinical pharmacology, 1998-02, Vol.53 (6), p.389-404

1998

Volltextzugriff (PDF)

Sleep Latency Is Shortened During 4 Weeks of Treatment With Zaleplon, a Novel Nonbenzodiazepine Hypnotic

The journal of clinical psychiatry, 1999-08, Vol.60 (8), p.536-544

1999

Volltextzugriff (PDF)

Post-traumatic stress disorder: Hypotheses from clinical neuropsychology and psychopharmacology research

International journal of psychiatry in clinical practice, 2000, Vol.4 (1), p.3-18

Emilien, C. Penasse, G. Charles, D. Martin, L. Lasseaux, A. Waltregny, G

2000

Volltextzugriff (PDF)

PRS65 - Title: Factors Influencing Consumers’ Perceived Risk Of Tobacco Products

Value in health, 2015-11, Vol.18 (7), p.A505-A505

2015

Volltextzugriff (PDF)

Title: Factors Influencing Consumers’ Perceived Risk Of Tobacco Products

Value in health, 2015-11, Vol.18 (7), p.A505-A505

2015

Volltextzugriff (PDF)

Dopamine receptors—physiological understanding to therapeutic intervention potential

Pharmacology & therapeutics (Oxford), 1999-11, Vol.84 (2), p.133-156

1999

Volltextzugriff (PDF)

Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine

Human psychopharmacology, 2004-08, Vol.19 (6), p.387-396

2004

Volltextzugriff (PDF)

Traumatic brain injury, cognitive and emotional dysfunction. Impact of clinical neuropsychology research

Acta neurologica Belgica, 1996-06, Vol.96 (2), p.89-101

1996

Volltextzugriff (PDF)

Use of a placebo in clinical trials

European psychiatry, 1998-08, Vol.13 (5), p.254-263

1998

Volltextzugriff (PDF)

Cognitive impairment in depressive disorders : Neuropsychological evaluation of memory and behavioural disturbances

Encéphale, 1998-03, Vol.24 (2), p.138-150

1998

Volltextzugriff (PDF)

Haemophilias: advances towards genetic engineering replacement therapy

Clinical and laboratory haematology, 2000-12, Vol.22 (6), p.313-323

2000

Volltextzugriff (PDF)

Pharmacological Management of Diabetes: Recent Progress and Future Perspective in Daily Drug Treatment

Pharmacology & therapeutics (Oxford), 1999, Vol.81 (1), p.37-51

1999

Volltextzugriff (PDF)

Zaleplon decreases sleep latency in outpatients after 4 weeks of treatment

European neuropsychopharmacology, 1998-11, Vol.8, p.S297-S297

1998

Volltextzugriff (PDF)

The dose-response relationship in Phase I clinical trials and beyond: use, meaning, and assessment

Pharmacology & therapeutics (Oxford), 2000-10, Vol.88 (1), p.33-58

2000

Volltextzugriff (PDF)

P.3.057 Treatment of panick disorder with venlafaxine XR

European neuropsychopharmacology, 2003-10, Vol.13, p.S377-S378

2003

Volltextzugriff (PDF)

P.3.058 Venlafaxine XR and paroxetine in the short-term treatment of panic disorder

European neuropsychopharmacology, 2003-10, Vol.13, p.S378-S378

2003

Volltextzugriff (PDF)

Future European health care: cost containment, health care reform and scientific progress in drug research

The International journal of health planning and management, 1997-04, Vol.12 (2), p.80-101

Emilien, G

1997

Volltextzugriff (PDF)

Future European health care: cost containment, health care reform and scientific progress in drug research

The International journal of health planning and management, 1997-04, Vol.12 (2), p.81-101

Emilien, Gérard

1997

Volltextzugriff (PDF)

Effects of clonidine, yohimbine and eserine on the quantified EEG of rats

Archives internationales de pharmacodynamie et de thérapie, 1990-03, Vol.304, p.105

Emilien, G

1990

Volltextzugriff (PDF)

Lithium compared to valproic acid and carbamazepine in the treatment of mania: a statistical meta-analysis

European neuropsychopharmacology, 1996-08, Vol.6 (3), p.245-252

1996

Volltextzugriff (PDF)

Prospects for pharmacological intervention in Alzheimer disease

Archives of neurology (Chicago), 2000-04, Vol.57 (4), p.454

2000

Volltextzugriff (PDF)

Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group

International journal of geriatric psychiatry, 2000-08, Vol.15 (8), p.704

2000

Volltextzugriff (PDF)

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Englisch
(161)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(116)
Engineering Sciences
(54)
Life Sciences & Biomedicine
(53)
Physics
(52)
Physical Sciences
(49)
Technology
(43)
Engineering
(37)
Engineering, Electrical & Electronic
(34)
Physics, Applied
(34)
Humans
(29)
Biological And Medical Sciences
(20)
Optics
(16)
Animals
(15)
Medical Sciences
(14)
Exact Sciences And Technology
(13)
Neurosciences & Neurology
(13)
Photodiodes
(12)
Clinical Neurology
(11)
Male
(11)
Pharmacology & Pharmacy
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of genomics on drug discovery and clinical medicine

Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia

Dopamine receptorsâphysiological understanding to therapeutic intervention potential

Current therapeutic uses and potential of β-adrenoceptor agonists and antagonists

Sleep Latency Is Shortened During 4 Weeks of Treatment With Zaleplon, a Novel Nonbenzodiazepine Hypnotic

Post-traumatic stress disorder: Hypotheses from clinical neuropsychology and psychopharmacology research

PRS65 - Title: Factors Influencing Consumers’ Perceived Risk Of Tobacco Products

Title: Factors Influencing Consumers’ Perceived Risk Of Tobacco Products

Dopamine receptors—physiological understanding to therapeutic intervention potential

Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine

Traumatic brain injury, cognitive and emotional dysfunction. Impact of clinical neuropsychology research

Use of a placebo in clinical trials

Cognitive impairment in depressive disorders : Neuropsychological evaluation of memory and behavioural disturbances

Haemophilias: advances towards genetic engineering replacement therapy

Pharmacological Management of Diabetes: Recent Progress and Future Perspective in Daily Drug Treatment

Zaleplon decreases sleep latency in outpatients after 4 weeks of treatment

The dose-response relationship in Phase I clinical trials and beyond: use, meaning, and assessment

P.3.057 Treatment of panick disorder with venlafaxine XR

P.3.058 Venlafaxine XR and paroxetine in the short-term treatment of panic disorder

Future European health care: cost containment, health care reform and scientific progress in drug research

Future European health care: cost containment, health care reform and scientific progress in drug research

Effects of clonidine, yohimbine and eserine on the quantified EEG of rats

Lithium compared to valproic acid and carbamazepine in the treatment of mania: a statistical meta-analysis

Prospects for pharmacological intervention in Alzheimer disease

Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group

Suchergebnisse filtern